Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 27981 | 177 | 27.9 | 65% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 667 | 12573 | ANTIDEPRESSANTS//AGOMELATINE//MOCLOBEMIDE |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | META NISOLDIPINE | Author keyword | 3 | 100% | 2% | 3 |
| 2 | VOLTAGE ACTIVATED | Author keyword | 2 | 67% | 1% | 2 |
| 3 | M NISOLDIPINE | Author keyword | 2 | 33% | 3% | 5 |
| 4 | FLUORINE MRS | Author keyword | 1 | 50% | 1% | 2 |
| 5 | IODONIUM COMPOUNDS | Author keyword | 1 | 40% | 1% | 2 |
| 6 | 31 PHOSPHORUS | Author keyword | 1 | 50% | 1% | 1 |
| 7 | CEREBROCORTICAL | Author keyword | 1 | 50% | 1% | 1 |
| 8 | CHRONIC FLUOXETINE TREATMENT | Author keyword | 1 | 50% | 1% | 1 |
| 9 | H 1 AND H 2 RECEPTORS | Author keyword | 1 | 50% | 1% | 1 |
| 10 | MED CHEM ALCOHOL DRUG ABUSE | Address | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | META NISOLDIPINE | 3 | 100% | 2% | 3 | Search META+NISOLDIPINE | Search META+NISOLDIPINE |
| 2 | VOLTAGE ACTIVATED | 2 | 67% | 1% | 2 | Search VOLTAGE+ACTIVATED | Search VOLTAGE+ACTIVATED |
| 3 | M NISOLDIPINE | 2 | 33% | 3% | 5 | Search M+NISOLDIPINE | Search M+NISOLDIPINE |
| 4 | FLUORINE MRS | 1 | 50% | 1% | 2 | Search FLUORINE+MRS | Search FLUORINE+MRS |
| 5 | IODONIUM COMPOUNDS | 1 | 40% | 1% | 2 | Search IODONIUM+COMPOUNDS | Search IODONIUM+COMPOUNDS |
| 6 | 31 PHOSPHORUS | 1 | 50% | 1% | 1 | Search 31+PHOSPHORUS | Search 31+PHOSPHORUS |
| 7 | CEREBROCORTICAL | 1 | 50% | 1% | 1 | Search CEREBROCORTICAL | Search CEREBROCORTICAL |
| 8 | CHRONIC FLUOXETINE TREATMENT | 1 | 50% | 1% | 1 | Search CHRONIC+FLUOXETINE+TREATMENT | Search CHRONIC+FLUOXETINE+TREATMENT |
| 9 | H 1 AND H 2 RECEPTORS | 1 | 50% | 1% | 1 | Search H+1+AND+H+2+RECEPTORS | Search H+1+AND+H+2+RECEPTORS |
| 10 | MONOAMINE UPTAKE SYSTEMS | 1 | 50% | 1% | 1 | Search MONOAMINE+UPTAKE+SYSTEMS | Search MONOAMINE+UPTAKE+SYSTEMS |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | FLUOXETINE INDUCED BRADYCARDIA | 6 | 100% | 2% | 4 |
| 2 | ANTIDEPRESSANT DRUG | 2 | 14% | 7% | 12 |
| 3 | PROZAC | 1 | 21% | 3% | 6 |
| 4 | 3 6 DIMETHAMIDODIBENZOPYRIODONIUM CITRATE I 65 | 1 | 100% | 1% | 2 |
| 5 | I 65 | 1 | 100% | 1% | 2 |
| 6 | ANTIDEPRESSANT FLUOXETINE | 1 | 23% | 2% | 3 |
| 7 | CARDIAC TISSUES | 1 | 21% | 2% | 3 |
| 8 | C 30 BONDED PHASE | 1 | 50% | 1% | 1 |
| 9 | INDUCED BRADYCARDIA | 1 | 15% | 2% | 4 |
| 10 | OUABAIN INDUCED ARRHYTHMIA | 0 | 33% | 1% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Fluorine magnetic resonance in vivo: A powerful tool in the study of drug distribution and metabolism | 2008 | 30 | 51 | 29% |
| Cardiovascular side effects of new antidepressants and antipsychotics: New drugs, old concerns? | 2004 | 124 | 126 | 23% |
| Speculations on difference between tricyclic and selective serotonin reuptake inhibitor antidepressants on their cardiac effects. Is there any? | 1999 | 63 | 129 | 14% |
| NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY - A REVIEW OF NEUROPSYCHIATRIC APPLICATIONS | 1995 | 32 | 111 | 10% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | MED CHEM ALCOHOL DRUG ABUSE | 1 | 50% | 0.6% | 1 |
| 2 | MR BIO | 1 | 50% | 0.6% | 1 |
| 3 | ANESTHESIOL PAIN MANAGEMENT SERV | 0 | 33% | 0.6% | 1 |
| 4 | CLIN IMAGING UNIT | 0 | 33% | 0.6% | 1 |
| 5 | COMBINED PSYCHIAT | 0 | 33% | 0.6% | 1 |
| 6 | CATHOLIC AGROMED | 0 | 17% | 0.6% | 1 |
| 7 | DIAGNOST IMAGING SCI | 0 | 17% | 0.6% | 1 |
| 8 | INTEGRATED PHARMACEUT | 0 | 13% | 0.6% | 1 |
| 9 | AUTISME PSYCHOSES EVOLUT LENTE ADULTE | 0 | 100% | 0.6% | 1 |
| 10 | NEUROPHARMACOL MAILMAN | 0 | 100% | 0.6% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000176903 | CYCLIC ANTIDEPRESSANT//AMITRIPTYLINE POISONING//TRICYCLIC ANTIDEPRESSANT POISONING |
| 2 | 0.0000148086 | SERTINDOLE//PSYCHOPHARMACOL VENTURE//TROP TOXINOL UNIT |
| 3 | 0.0000138772 | NORFLUOXETINE//FLUVOXAMINE//CITALOPRAM |
| 4 | 0.0000130343 | BARWON BIOMED//SEROTONIN 2B RECEPTOR//BONE QCT MICROCT |
| 5 | 0.0000123300 | F 19 MRI//FLUORINE STUDIES//19F MRI |
| 6 | 0.0000085290 | SR 33557//SR33805//H 3PN200 110 |
| 7 | 0.0000085047 | M 3M3FBS//OC2//NPC 14686 |
| 8 | 0.0000081708 | N ACETYL ASPARTATE//N ACETYLASPARTATE//MOL DYNAM MENTAL DISORDERS |
| 9 | 0.0000068341 | IN VIVO O 17 NMR//O 17 MRS//CEREBRAL METABOLIC RATE OF OXYGEN UTILIZATION |
| 10 | 0.0000065226 | MUSCULAR TRYPTAMINERGIC RECEPTOR//USTAV CHEM//ALFA1 RECEPTORS |